CPRX Operating Cash Flow Growth
Catalyst Pharmaceuticals Inc · Operating Cash Flow Growth
CPRX Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-22.29%period ending
CPRX TTM Cash from Operations YoY % (-25.94% → -22.29%)
Year-over-year change
High-resolution chart · PNG
CPRX operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -22.2868% | |
| -12.9846% | |
| 4.4871% | |
| 39.7554% | |
| 63.9142% | |
| 66.9972% | |
| 75.4126% | |
| 58.4805% | |
| 36.6235% | |
| 23.743% | |
| 34.5606% | |
| 64.3927% | |
| 83.9581% | |
| 92.2199% | |
| 75.2178% | |
| 71.531% | |
| 56.2022% | |
| 34.0561% | |
| 22.7966% | |
| -10.17% | |
| -16.3727% | |
| 30.1154% | |
| 215.7158% | |
| 641.2458% | |
| 280.4822% | |
| 234.6519% | |
| 165.3876% | |
| 47.4849% | |
| -73.0038% | |
| -87.0422% | |
| -51.6572% | |
| -16.7975% | |
| -0.2073% | |
| 23.4973% | |
| 22.321% | |
| 27.0573% | |
| 21.0333% | |
| 0.2871% | |
| -4.718% | |
| -30.0166% | |
| -40.7971% | |
| -39.202% | |
| -32.6286% | |
| -38.763% | |
| -42.3836% | |
| -31.0471% | |
| -78.3857% | |
| -66.1176% | |
| -65.0961% | |
| -92.1201% | |
| -47.2323% | |
| -31.5326% | |
| -11.6046% | |
| -3.1157% | |
| -15.4951% | |
| -32.3594% | |
| -52.9386% | |
| -32.6727% | |
| -13.0685% | |
| 10.8507% | |
| 39.2155% | |
| 51.0958% | |
| 60.8697% | |
| 60.1443% | |
| 40.5635% | |
| 6.9878% | |
| -55.037% | |
| -144.674% | |
| -130.499% | |
| -86.6788% | |
| -50.8798% | |
| -25.9401% |